Added to YB: 2025-06-10
Pitch date: 2025-06-07
CLPT [bullish]
ClearPoint Neuro, Inc.
-33.71%
current return
Author Info
MVC Investing is a long-term investor. BSc in Economics, MSc in Finance. Equity Analyst with a focus on Fundamental Analysis and Valuation. Sign up for the newsletter.
Company Info
ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States.
Market Cap
$272.3M
Pitch Price
$14.15
Price Target
N/A
Dividend
N/A
EV/EBITDA
-14.10
P/E
-10.18
EV/Sales
7.70
Sector
Health Care Equipment and Supplies
Category
growth
Clearpoint Neuro (CLPT): Investment Thesis Explained
CLPT: MRI-guided neurosurgery platform evolving into high-margin CNS drug delivery infrastructure. Supporting 60+ biopharma partners in clinical trials. Q1 revenue $8.2M (+12% YoY) with neurosurgery segment +70%. $12.4M cash + $105M facility. Platform embedded in drug regulatory submissions creates switching costs. First commercial therapies expected 2025-2027.
Read full article (22 min)